Heart & blood pressure · Boston area, MA
Heart and blood pressure studies in Boston area, MA
87 recruiting studies have a site in the Boston area. This page includes nearby cities such as Cambridge, Brookline, Newton, Waltham.
87 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 1/Phase 2
ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy
Alexion Pharmaceuticals, Inc.
- Location
- Boston, MA + 6 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Cytokinetics
- Location
- Boston, MA + 23 other US sites
- Eligibility basics
- Ages 40–85
- Recruiting
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
Javelin Medical
- Location
- Boston, MA + 3 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Alleviant ALLAY-HF Study
Alleviant Medical, Inc.
- Location
- Boston, MA + 42 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
- Location
- Boston, MA + 39 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
FORWARD CAD IDE Study
Shockwave Medical, Inc.
- Location
- Boston, MA + 27 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Teleflex
- Location
- Boston, MA + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Anthos Therapeutics, Inc.
- Location
- Boston, MA + 131 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 2/Phase 3
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Kardigan, Inc.
- Location
- Boston, MA + 46 other US sites
- Eligibility basics
- Ages 50+
- Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Endotronix, Inc.
- Location
- Boston, MA + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Novartis Pharmaceuticals
- Location
- Boston, MA + 29 other US sites
- Eligibility basics
- Ages 50–80
- Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Medical Devices
- Location
- Boston, MA + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc.
- Location
- Boston, MA + 19 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Medtronic Terminate AF Study
Medtronic Cardiac Surgery
- Location
- Boston, MA + 6 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Cardiac Dimensions, Inc.
- Location
- Boston, MA + 50 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control
Aktiia SA
- Location
- Boston, MA
- Eligibility basics
- Ages 21–85
- RecruitingPhase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Intellia Therapeutics
- Location
- Boston, MA + 36 other US sites
- Eligibility basics
- Ages 18–90
- Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Edwards Lifesciences
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Boston, MA + 34 other US sites
- Eligibility basics
- Ages 12–18
- Recruiting
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Aria CV, Inc
- Location
- Boston, MA + 8 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System
Vectorious Medical Technologies Ltd.
- Location
- Boston, MA
- Eligibility basics
- Ages 22–88
- RecruitingPhase 1
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Tenaya Therapeutics
- Location
- Boston, MA + 6 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
XSpline S.p.A.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18+
- Recruiting
PARTNER 3 Trial - Aortic Valve-in-Valve
Edwards Lifesciences
- Location
- Boston, MA + 28 other US sites
- Eligibility basics
- Any age listed
Who these studies look for
Many require a diagnosis or specific lab values such as LDL cholesterol or blood pressure readings, and exclude recent heart events.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.